Skip to content

Comparison of perfusion index in response to noxious stimulation under monitored anesthesia care: propofol / remifentanil vs propofol / dexmedetomidine

Comparison of perfusion index in response to noxious stimulation under monitored anesthesia care: propofol / remifentanil vs propofol / dexmedetomidine

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CRIS
Registry ID
KCT0003501
Enrollment
76
Registered
2019-02-13
Start date
2019-02-15
Completion date
Unknown
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

None listed

Sponsors

Samsung Medical Center
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologist (ASA) class I, II Adult patients

Exclusion criteria

Exclusion criteria: Pediatric patients Patients with American Society of Anesthesiologist (ASA) class III, IV Patients with a Body mass index (BMI) greater than 30 Diabetes Peripheral obstructive blood vessel disease Patients with heart disease (myocardial infarction, heart failure, arrhythmia) Patients who is taking a / ß blocker pregnancy Anyone who is allergic to certain anesthetics or drugs due to a history (propopol related allergy or history: previous hypersensitivity reactions, hypersensitivity to soy or peanuts) bradycardia (HR < 50 bpm) Chronic pain disorder Severe liver, kidney disease

Design outcomes

Primary

MeasureTime frame
When remifentanil or dexmedetomidine are used for monitoring and undergoing anesthesia, the difference in perfusion index between the two groups is checked at postanesthesia care unit.

Secondary

MeasureTime frame
Check the difference in perfusion index between the two groups according to the surgical stimulation during the operation (local infiltraion at surgical site, dilator insertion, and skin suture).

Countries

Korea, Republic of

Contacts

Public ContactDoyeon Kim

Samsung Medical Center

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 11, 2026